RU2002129171A -
RECOMBINANT ATTENUATED STRAIN OF BACTERIA SALMONELLA ENTERIDITIS E-23 / PGEX-2T-TBI AS A CANDIDATE FOR CONSTRUCTION OF A LIVING Vaccine Against Human Immunodeficiency Virus
- Google Patents
RECOMBINANT ATTENUATED STRAIN OF BACTERIA SALMONELLA ENTERIDITIS E-23 / PGEX-2T-TBI AS A CANDIDATE FOR CONSTRUCTION OF A LIVING Vaccine Against Human Immunodeficiency Virus
Info
Publication number
RU2002129171A
RU2002129171ARU2002129171/13ARU2002129171ARU2002129171ARU 2002129171 ARU2002129171 ARU 2002129171ARU 2002129171/13 ARU2002129171/13 ARU 2002129171/13ARU 2002129171 ARU2002129171 ARU 2002129171ARU 2002129171 ARU2002129171 ARU 2002129171A
Государственный научный центр вирусологии и биотехнологии "Вектор"
Filing date
Publication date
Application filed by Государственный научный центр вирусологии и биотехнологии "Вектор"filedCriticalГосударственный научный центр вирусологии и биотехнологии "Вектор"
Priority to RU2002129171/13ApriorityCriticalpatent/RU2237089C2/en
Priority claimed from RU2002129171/13Aexternal-prioritypatent/RU2237089C2/en
Publication of RU2002129171ApublicationCriticalpatent/RU2002129171A/en
Application grantedgrantedCritical
Publication of RU2237089C2publicationCriticalpatent/RU2237089C2/en
Рекомбинантный аттенуированный штамм бактерий Salmonella enteriditis E-23/pGEX-2T-TBI, депонированный в коллекции НИИ ККМ ГНЦ ВБ "Вектор" под номером В-884, - продуцент искусственного белка-иммуногена TBI, содержащего эпитопы нескольких белков ВИЧ-1.The recombinant attenuated bacterial strain Salmonella enteriditis E-23 / pGEX-2T-TBI, deposited in the collection of the Research Institute of KKM SSC VB "Vector" under the number B-884, is a producer of the artificial TBI immunogen protein containing epitopes of several HIV-1 proteins.
RU2002129171/13A2002-10-312002-10-31Recombinant attenuated strain of bacterium salmonella enteriditis e-23/pgex-2t-tbi as candidate for construction of live vaccine against human immunodeficiency virus
RU2237089C2
(en)
Recombinant attenuated strain of bacterium salmonella enteriditis e-23/pgex-2t-tbi as candidate for construction of live vaccine against human immunodeficiency virus
Recombinant attenuated strain of bacterium salmonella enteriditis e-23/pgex-2t-tbi as candidate for construction of live vaccine against human immunodeficiency virus
Recombinant attenuated strain of bacterium salmonella enteriditis e-23/pgex-2t-tbi as candidate for construction of live vaccine against human immunodeficiency virus
Immunogenic peptides for use in the prophylaxis and / or treatment of infectious diseases, autoimmune diseases, the immune response to allogeneic FACTORS, allergic diseases, tumor, transplant rejection and immune responses against viral vectors USED FOR GENE THERAPY OR GENE VACCINATION
Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA.
Flexibility in MHC and TCR recognition: degenerate specificity at the T cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology
RECOMBINANT ATTENUATED STRAIN OF BACTERIA SALMONELLA ENTERIDITIS E-23 / PGEX-2T-TBI AS A CANDIDATE FOR CONSTRUCTION OF A LIVING Vaccine Against Human Immunodeficiency Virus
Antibodies to interleukin-1 raised with synthetic peptides: identification of external sites and analysis of interleukin-1 synthesis in stimulated human peripheral blood monocytes.